Tolerogenic Immunotherapy

Tolerogenic Immunotherapy is a therapeutic strategy within mucosal immunopharmacology that belongs to the class of immunomodulatory interventions and is differentiated by its specific induction of immune tolerance to prevent or suppress pathological immune responses without compromising host defense.

184

Publications

10.1K

Citations

1.3K

Authors

420

Institutions

Publications per year

2017–2026

55

Authors

1.3K

  1. MD
    Mark D. Mannie

    East Carolina University, United States

    10 publications · 205 citations

    10

    h-index

  2. DJ
    Derek J. Abbott

    East Carolina University, United States

    5 publications · 103 citations

    5

    h-index

  3. YB
    Yves Borel

    Harvard University, United States

    4 publications · 46 citations

    4

    h-index

  4. AD
    Alan D. Curtis

    University of California, Davis, United States

    4 publications · 70 citations

    4

    h-index

  5. LB
    Lori Blanchfield

    Emory University, United States

    4 publications · 94 citations

    4

    h-index

1–5 of 1.3K

Venues

  1. The Journal of Immunology

    JI · 19 publications · 1.4K citations

    16

    h-index

  2. Frontiers in Immunology

    13 publications · 351 citations

    11

    h-index

  3. Proceedings of the National Academy of Sciences

    PNAS · 6 publications · 453 citations

    6

    h-index

  4. PLoS ONE

    6 publications · 338 citations

    6

    h-index

  5. Transplantation

    6 publications · 214 citations

    6

    h-index

1–5